GXE:ETR
Lakefront Biotherapeutics NV
26,14 €
arrow_downward
-0,53%(-0,14) 1K
14-okt, 17:35:46 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoGXE tikeri uchun statistika yaratilmoqda...
Ochish
25,98 €
Yuqori
26,14 €
Past
25,74 €
Bozor kapitali
1,72Â mlrd
Oʻrtacha hajm
572,00
Hajmi
574,00
P/E koeffitsiyenti
2,89
52 haftalik eng yuqori
30,02 €
52 haftalik eng past
22,84 €
Aksiya boʻyicha daromad
9,05 €
Xodimlar soni
196
Ochish
25,98 €
Yuqori
26,14 €
Past
25,74 €
Bozor kapitali
1,72Â mlrd
Oʻrtacha hajm
572,00
Hajmi
574,00
P/E koeffitsiyenti
2,89
52 haftalik eng yuqori
30,02 €
52 haftalik eng past
22,84 €
Aksiya boʻyicha daromad
9,05 €
Xodimlar soni
196
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
1 soat oldin
SKHY Tracks Worst Month Since Nasdaq Debut: SK Hynix Reportedly Wants To Ship More Chip Tools To China Before Building In US
Trefis
·
39 daqiqa oldin
The 52-Week-High List: 18 S&P 500 Names On Wednesday
www.marketscreener.com
·
35 daqiqa oldin
IPAS Indexo : INDEXO submits draft Company Description to Nasdaq Stockholm for preliminary review
Investor's Business Daily
·
2 soat oldin
Tech Futures Fall; Anthropic Revenue Jumps, But Not Enough?
Profil
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Lakefront Biotherapeutics NV haqida
CEOPaul Stoffels | Paul Stoffels
Xodimlar soni196
Asos solingan1999
Bosh ofislar-
Sektor-
Veb-saytlakefrontbio.com